Director Paul Seid filed a Form 4 with the SEC on November 6, 2026, disclosing the acquisition of 4,771 shares of BGSF, Inc. common stock on November 4, 2026, at a price of $0 per share.
Director Donna Carroll of BGSF, Inc. filed a Form 4 on November 6, 2026, disclosing the acquisition of 4,771 shares of common stock on November 4, 2026, at a price of $0 per share.
A Form 4 filed on November 6, 2026 reports that Allen C. David Jr., a director of BGSF, Inc. (NYSE:BGSF), acquired 4,771 shares of common stock on November 4, 2026 at a price of $0 per share.
Baker Bros. Advisors LP and affiliated reporting persons filed a Form 4 with the SEC on November 6, 2026, disclosing purchases of Kodiak Sciences Inc. common stock on November 4 and November 5, 2026.
Faraday Future Intelligent Electric Inc. filed a Form 8-K on November 6, 2026, disclosing that on November 4, 2026, it sold one share of newly designated Series A Preferred Stock to its Executive Chairman, Jiawei Wang, for $100.00, primarily to facilitate a potential reverse …
Faraday Future Intelligent Electric Inc. Executive Chairman Wang Jiawei filed a Form 4 on November 6, 2026, disclosing the purchase of one share of Series A Preferred Stock from the issuer on November 5, 2026, for $100.00 in cash.
Director Douglas J. Treff filed a Form 4 with the SEC on November 6, 2026, disclosing the sale of 10,714 shares of Crocs, Inc. common stock on November 4, 2026.
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corp (NASDAQ:UTHR), filed a Form 4 on November 6, 2026, disclosing the exercise of 9,500 stock options and the sale of common stock on November 5, 2026, pursuant to a pre-arranged Rule 10b5-1 trading plan.
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corp (NASDAQ:UTHR), filed a Form 4 on November 6, 2026, disclosing nine separate sales of common stock totaling 1,960 shares on November 5, 2026, executed under a pre-arranged 10b5-1 trading plan.
Maurice J. Duca, a 10% owner of AppFolio Inc. (NASDAQ:APPF), filed a Form 4 on November 6, 2026, disclosing sales of Class A Common Stock across six transactions on November 4 and 5, 2026, executed under a previously adopted Rule 10b5-1 trading plan.